Draft Course Schedule
Tuesday, March
12,
2024
|
7:00 – 8:00 am |
Continental Breakfast |
All participants |
|
7:00 - 8:00 am |
Registration & badge pickup |
All participants |
|
8:00 – 8:50 am |
Overview: Neurotherapeutics Discovery and Development Process |
Michael A. Rogawski, M.D., Ph.D., University of California, Davis |
|
8:50 – 9:40 am |
Session 1: Target and Pathway Interrogation |
James Inglese, Ph.D., National Center for Advancing Translational Sciences, NIH |
|
9:40 - 10:30 am |
Session 2: Moving from Hit to Lead to Clinical Candidate |
James Barrow, Ph.D., Johns Hopkins School of Medicine |
|
10:30 – 11:00 am |
BREAK |
|
|
11:00 - 11:50 am |
Session 3: ADME |
Kennan Marsh, Ph.D., AbbVie |
|
11:10 am - 12:00 pm |
Session 4: Toxicology |
Ruokun Wang, Ph.D., DABT, Biogen |
|
12:00 - 1:30 pm |
LUNCH Engagement Exercise 1: Meet Your Mentors |
Mentor Teams |
|
1:30 - 2:20 pm |
Session 5: Formulation and Routes of Administration |
Maureen Donovan, Ph.D., University of Iowa |
|
2:20 - 3:10 pm |
Session 6: Alternative Routes of Administration |
James Cloyd, III, Pharm.D., University of Minnesota |
|
3:10 - 3:25 pm |
BREAK |
|
|
3:25 - 3:30 pm |
Introduction to Round Robins |
Course Directors |
|
3:30 - 5:30 pm |
Engagement Exercise 2: Round Robins 1 |
Mentor Teams |
|
5:30 pm - 6:00 pm |
BREAK |
|
|
6:00 pm - 8:00 pm |
DINNER - ASENT Career Dinner |
All participants |
Wednesday, March
13,
2024
|
7:00 – 8:00 am |
Continental Breakfast |
All participants |
|
8:00 - 8:50 am |
Session 7: Animal Models |
Greg Carr, Ph.D., Johns Hopkins School of Medicine |
|
8:50 - 9:40 am |
Session 8: Adeno-associated viral vector (AAVs) |
Luk Vandenberghe, Ph.D., Grousbeck Gene Therapy Center, Mass Eye and Ear |
|
9:40 – 10:00 am |
BREAK |
|
|
10:00 - 10:50 am |
Session 9: Antisense Oligonucleotides |
Gene Liau, Ph.D., Adagen |
|
10:50 - 11:40 am |
Session 10: Antibody Therapies |
Gai Ayalon, Ph.D., Neumora |
|
11:40 am – 1:00 pm |
LUNCH Responsible Conduct of Research Exercise |
Mentor Teams |
|
1:00 - 1:50 pm |
Session 11: Cellular Therapies |
Arnold R. Kriegstein M.D., Ph.D., UCSF School of Medicine |
|
1:50 - 2:40 pm |
Session 12: Rigor in Translational Drug Discovery and Development |
Shai Silberberg, Ph.D., NIH/NINDS |
|
2:40 - 2:55 pm |
BREAK |
|
|
2:55 - 4:55 pm |
Engagement Exercise 3: Round Robin 2 |
Mentor Teams |
|
5:00 - 6:00 pm |
BREAK |
|
|
6:00 – 8:00 pm |
Dinner and Guest Lecture |
Irfan Qureshi, M.D., Biohaven |
Thursday, March
14, 2024
|
7:00 – 8:00 am |
Continental Breakfast |
All participants |
|
8:00 – 8:50 am |
Session 13: Intellectual Property |
Jeffrey Childers, J.D., Ph.D., Casimir Jones |
|
8:50 – 9:40 am |
Session 14: Clinical Considerations in the Non-Clinical Phase of Drug Discovery and Development |
James J. Vornov, M.D., Ph.D., Johns Hopkins School of Medicine and Medpace |
|
9:40 – 10:00 am |
BREAK |
|
|
10:00 – 10:50 am |
Session 15: Funding Academic Drug Discovery Research |
Charles L. Cywin, Ph.D., NIH/NINDS |
|
10:50 - 11:40 am |
Session 16: Partners and Investors (Title tentative) |
Matt Tremblay, Ph.D., Scripps and Calibr |
|
11:40 am - 12:30 pm |
LUNCH |
All |
|
12:30 pm -2:30pm |
Engagement Exercise 4: Round Robin 3 |
Mentor Teams |
|
2:30 - 5:30 pm |
NCATS Tour |
|
|
6:00 – 8:00 pm |
Off-site Dinner - TBD |
All |
Friday, March
15,
2024
|
7:00 -8:00 am |
Continental Breakfast |
All participants |
|
8:00 - 8:15 am |
Intro to Presentations |
Course Directors |
|
8:15 – 11:30 am |
Engagement Exercise 4: Student Presentations |
Mentor Teams |
|
11:30 am - 12:00 pm |
Conclusion: Where do we go from here? Course evaluation; survey |
Course Directors |
|
12:00 pm |
Adjourn - LUNCH grab & go |
|
